跳至主要内容
临床试验/ITMCTR2100004650
ITMCTR2100004650招募中1 期

Research on the characteristics of TCM constitution and adverse metabolic reactions of antipsychotic drugs in patients with first-episode schizophrenia

Hangzhou Seventh Peoples Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
18 至 40(—)
性别
All

入选标准

  • 1.ICD-10 diagnostic criteria for schizophrenia, schizoid psychosis or schizoaffective disorder; Hospitalized or outpatient patients;
  • 2. No gender limitation, aged 18 to 40 years;
  • 3.(1)The first attack, the course of disease is not more than 2 years;
  • (2)The duration of continuous treatment for never taking medication or taking the same antipsychotic medication is <2 weeks, and the cumulative duration of antipsychotic exposure is <6 weeks.;
  • 4. Able to complete questionnaires under the guidance of clinical researchers, use APP, agree to informed consent and participate voluntarily;
  • 5. Body mass index (BMI) is not less than 17.0kg/m2;
  • 6. No language or hearing impairment.

排除标准

  • 1. Disease is not the diagnosis of schizophrenia, such as dissociation disorder, bipolar disorder, depression, schizoaffective disorder, etc.;
  • 2. In the 6 months before screening, active substance dependence (excluding nicotine and caffeine dependence) was diagnosed;
  • 3. Patients with a severe tendency to suicide within 12 months prior to screening or violence as clinically assessed during the screening;
  • 4. Past or present suffering from any serious or unstable cardiovascular, respiratory, neurological (including epilepsy or major cerebrovascular), kidney, liver, blood, uncontrolled diabetes, glaucoma, or other system diseases. Coma, delirium, mild-to-moderate or severe mental retardation, there can result in long QT, ventricular tachycardia or sudden death risk factors;
  • 5. The results of blood routine, biochemical, hematological and electrocardiogram examinations are not within the normal range of laboratory values and have clinical significance as judged by researchers;
  • 6. Evidence of liver disease at the time of prior or screening;
  • 7. Previous neuroblocker malignant syndrome (NMS) or tardive dyskinesia;
  • 8. Women who are pregnant, breastfeeding or who plan to become pregnant within 6 months;
  • 9. Patients with previous mental retardation or mental retardation;
  • 10. Participated in other clinical studies within 30 days before screening.

研究者

发起方
Hangzhou Seventh Peoples Hospital

相似试验